Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,202 | 95 | 98.8% |
| Education | $26.23 | 2 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $284.94 | 13 | $0 (2023) |
| Endo Pharmaceuticals Inc. | $234.72 | 9 | $0 (2020) |
| Astellas Pharma US Inc | $208.09 | 11 | $0 (2023) |
| PFIZER INC. | $188.15 | 9 | $0 (2024) |
| NeoTract Inc. | $142.41 | 3 | $0 (2019) |
| AbbVie Inc. | $126.61 | 7 | $0 (2021) |
| NxThera, Inc. | $121.75 | 2 | $0 (2017) |
| Boston Scientific Corporation | $96.43 | 2 | $0 (2019) |
| Antares Pharma, Inc. | $73.44 | 4 | $0 (2022) |
| Dendreon Pharmaceuticals LLC | $66.21 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $257.98 | 11 | PFIZER INC. ($77.89) |
| 2023 | $204.58 | 9 | Janssen Biotech, Inc. ($54.73) |
| 2022 | $143.57 | 8 | Myovant Sciences Inc. ($39.30) |
| 2021 | $188.40 | 9 | Janssen Biotech, Inc. ($49.59) |
| 2020 | $92.21 | 5 | Janssen Biotech, Inc. ($41.48) |
| 2019 | $599.50 | 24 | NeoTract Inc. ($109.55) |
| 2018 | $212.77 | 12 | AbbVie, Inc. ($52.89) |
| 2017 | $528.98 | 19 | Endo Pharmaceuticals Inc. ($168.37) |
All Payment Transactions
97 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/02/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $29.12 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $25.61 | General |
| Category: UROTHELIAL CANCER | ||||||
| 10/08/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Oncology | ||||||
| 09/25/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $27.08 | General |
| Category: UROLOGY | ||||||
| 09/11/2024 | Alnylam Pharmaceuticals Inc. | GIVLAARI (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Genetic Disease | ||||||
| 08/20/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $25.76 | General |
| Category: ONCOLOGY | ||||||
| 08/07/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: Oncology | ||||||
| 04/03/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Oncology | ||||||
| 02/12/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: ONCOLOGY | ||||||
| 01/31/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $27.08 | General |
| Category: UROLOGY | ||||||
| 01/12/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $22.21 | General |
| Category: ONCOLOGY | ||||||
| 12/14/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $29.64 | General |
| Category: Oncology | ||||||
| 12/05/2023 | PFIZER INC. | XTANDI (Drug), ORGOVYX, COMIRNATY | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: ONCOLOGY | ||||||
| 08/16/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $25.09 | General |
| Category: Oncology | ||||||
| 08/02/2023 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Oncology | ||||||
| 06/07/2023 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: ONCOLOGY | ||||||
| 06/01/2023 | Tolmar, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $29.40 | General |
| Category: Prostate Cancer | ||||||
| 05/16/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: Urology | ||||||
| 03/28/2023 | PFIZER INC. | XTANDI (Drug), ORGOVYX, COMIRNATY | Food and Beverage | In-kind items and services | $25.39 | General |
| Category: ONCOLOGY | ||||||
| 03/01/2023 | PROCEPT BioRobotics Corporation | AQUABEAM ROBOTIC SYSTEM (Device) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Urology | ||||||
| 11/01/2022 | PFIZER INC. | XTANDI (Drug), ORGOVYX, COMIRNATY | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: ONCOLOGY | ||||||
| 10/27/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Urology | ||||||
| 09/07/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: Urology | ||||||
| 09/06/2022 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $26.19 | General |
| Category: Oncology | ||||||
| 08/18/2022 | Myovant Sciences Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: HORMONE THERAPY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,503 | 1,944 | $327,826 | $87,653 |
| 2022 | 14 | 1,368 | 1,638 | $286,606 | $78,379 |
| 2021 | 12 | 1,352 | 1,621 | $239,253 | $69,125 |
| 2020 | 15 | 1,575 | 1,894 | $269,933 | $73,330 |
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 393 | 496 | $74,865 | $29,179 | 39.0% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 74 | 97 | $62,274 | $17,053 | 27.4% |
| 99426 | Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 63 | 158 | $15,800 | $7,322 | 46.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 55 | 55 | $21,750 | $6,266 | 28.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 71 | 74 | $15,250 | $5,769 | 37.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 37 | 87 | $9,135 | $4,251 | 46.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 53 | 53 | $14,074 | $4,057 | 28.8% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 36 | 36 | $21,600 | $3,453 | 16.0% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 289 | 359 | $43,439 | $2,676 | 6.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 37 | 45 | $5,175 | $1,751 | 33.8% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 16 | 37 | $2,960 | $1,370 | 46.3% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 14 | 23 | $7,176 | $1,082 | 15.1% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2023 | 36 | 36 | $11,016 | $886.89 | 8.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 88 | 104 | $2,496 | $865.20 | 34.7% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2023 | 36 | 36 | $16,848 | $836.94 | 5.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 205 | 248 | $3,968 | $835.45 | 21.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 373 | 479 | $71,850 | $29,699 | 41.3% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 91 | 111 | $71,262 | $20,169 | 28.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 69 | 74 | $15,170 | $6,728 | 44.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 57 | 57 | $22,540 | $6,009 | 26.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 55 | 55 | $14,575 | $4,171 | 28.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 59 | 71 | $8,165 | $2,531 | 31.0% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 260 | 312 | $37,752 | $2,371 | 6.3% |
| 55700 | Biopsy of prostate gland | Facility | 2022 | 20 | 20 | $12,000 | $2,051 | 17.1% |
| 76873 | Ultrasound scan of prostate through rectum | Office | 2022 | 11 | 11 | $5,500 | $1,562 | 28.4% |
About Dr. Kevin O'connor, MD
Dr. Kevin O'connor, MD is a Urology healthcare provider based in Leesburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1730173279.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kevin O'connor, MD has received a total of $2,228 in payments from pharmaceutical and medical device companies, with $257.98 received in 2024. These payments were reported across 97 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($2,202).
As a Medicare-enrolled provider, O'connor has provided services to 5,798 Medicare beneficiaries, totaling 7,097 services with total Medicare billing of $308,487. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Leesburg, VA
- Active Since 09/09/2005
- Last Updated 11/30/2022
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1730173279
Products in Payments
- XIAFLEX (Biological) $188.65
- XTANDI (Drug) $173.95
- ERLEADA (Drug) $171.99
- Erleada (Drug) $124.55
- Rezum (Device) $121.75
- UroLift (Device) $109.55
- MYRBETRIQ (Drug) $98.17
- Myrbetriq (Drug) $92.33
- GENERAL THERAPIES (Device) $77.99
- GEMTESA (Drug) $67.05
- Androgel (Drug) $66.44
- PROVENGE (Drug) $66.21
- XYOSTED (Drug) $59.90
- CAMCEVI (Drug) $58.95
- ELIGARD (Drug) $51.61
- vitagel (Device) $41.99
- Axumin (Drug) $41.57
- Nubeqa (Drug) $39.44
- ORGOVYX (Drug) $39.30
- Urolift - UL400 (Device) $32.86
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Leesburg
Dr. Jennifer Young, Md, MD
Urology — Payments: $16,281
Dr. Walter O'brien, Md, MD
Urology — Payments: $15,699
Dr. Kambiz Tajkarimi, Md, MD
Urology — Payments: $12,138
Gregory Schenk, Md, MD
Urology — Payments: $9,206
Chuck Pruna, D.o, D.O
Urology — Payments: $8,277
Christine Tran, Md, MD
Urology — Payments: $6,256